Diagnosis and Management of the Dermatologic Manifestations of Polycystic Ovary Syndrome

July 2006 in “ Dermatologic therapy ”

Eve J. Lowenstein

polycystic ovary syndrome PCOS hyperandrogenism acne hirsutism alopecia acanthosis nigricans insulin resistance cutaneous hyperandrogenism hair loss skin darkening excess hair growth

Studysummary This article reviews the diagnosis and treatment approaches for cutaneous manifestations of PCOS, reporting on various treatment options without presenting new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The document discusses Polycystic ovary syndrome (PCOS), which is the most common endocrine disorder affecting women of reproductive age, characterized by a range of hyperandrogenic symptoms. The skin-related issues associated with PCOS, such as acne, hirsutism, alopecia, obesity, and acanthosis nigricans, are particularly distressing for patients, although PCOS also leads to menstrual irregularities and infertility. Insulin resistance plays a significant role in the development of PCOS and its broader health implications. The paper outlines the importance of accurate diagnosis and recognition of cutaneous hyperandrogenism, reviews differential diagnoses, and presents an approach for evaluating patients with PCOS. While there is no consensus on a treatment strategy for the dermatologic symptoms of PCOS, the document provides information on various treatment options and the author's preferred treatment methods.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

38 / 38 results

research Finasteride Treatment for One Year in 35 Hirsute Patients

27 citations , July 2009 in “Experimental and Clinical Endocrinology & Diabetes”

This study found that finasteride significantly improved hirsutism scores in women over 12 months and was well-tolerated with no serious side effects.

research Hirsutism and Acne in Polycystic Ovary Syndrome

169 citations , August 2004 in “Baillière's best practice & research. Clinical obstetrics & gynaecology/Baillière's best practice and research in clinical obstetrics and gynaecology”

This article discusses treatments for hirsutism and acne in women with polycystic ovary syndrome, suggesting that lower doses of current medications maintain efficacy while reducing cost and side effects, but reports no new clinical results.

research The Pathophysiology of Polycystic Ovary Syndrome: Understanding PCOS and Its Endocrinology

131 citations , August 2004 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”

This article reviews the complex pathophysiology of polycystic ovary syndrome, highlighting how genetic, hormonal, and environmental factors contribute to its diverse symptoms, and reports no new results.

research Definitions, Prevalence, and Symptoms of Polycystic Ovaries and Polycystic Ovary Syndrome

278 citations , August 2004 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”

This article reviews the updated ESHRE/ASRM criteria for diagnosing polycystic ovary syndrome, emphasizing the need for continued research and collaboration, but reports no new clinical results.

research Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome

24 citations , January 2004 in “The scientific world journal/TheScientificWorldjournal”

This study found that HAIR-AN syndrome is prevalent among young women, and a multifaceted treatment approach effectively reduces symptom severity and prevents further consequences.

research Medical Treatment Regimens of Hirsutism

12 citations , January 2004 in “Reproductive biomedicine online”

This review discusses the main features of anti-androgen drugs, combined treatments, and insulin sensitizers in managing hirsutism and reports no new research findings.

research Prevalence of Polycystic Ovaries in Women with Androgenic Alopecia

84 citations , November 2003 in “European journal of endocrinology”

This study found that women with androgenic alopecia had a higher prevalence of polycystic ovarian morphology and higher androgen levels compared to controls, suggesting a strong association with PCO.

research Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome

192 citations , September 2003 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

This study suggests that metformin may be more effective than Dianette in treating moderate to severe hirsutism in women with PCOS, while also reducing markers of insulin resistance.

research The Evaluation and Management of Hirsutism

195 citations , May 2003 in “Obstetrics and gynecology (New York. 1953. Online)/Obstetrics and gynecology”

This review discusses the diagnosis and treatment of hirsutism, emphasizing that a systematic evaluation can determine its cause, while combination therapy effectively manages the condition for most patients.

research Update and Future of Hormonal Therapy in Acne

78 citations , January 2003 in “Dermatology”

This article reviews hormonal therapy as a treatment for acne in women and suggests that emerging research on hormone synthesis and metabolism in the skin could guide future drug development.

research Comparison of High-Dose Finasteride (5 mg/day) Versus Low-Dose Finasteride (2.5 mg/day) in the Treatment of Hirsutism

51 citations , October 2002 in “European journal of endocrinology”

This study found that both high-dose and low-dose finasteride significantly reduced hirsutism scores in women after 12 months, with the lower dose being safe and cost-effective.

research The Effect of Metformin on Hirsutism in Polycystic Ovary Syndrome

90 citations , August 2002 in “European journal of endocrinology”

This study found that metformin treatment significantly improved hair growth in women with PCOS and hirsutism compared to a placebo.

A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-Alpha-Reductase in the Treatment of Androgenetic Alopecia

research A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-Alpha-Reductase in the Treatment of Androgenetic Alopecia

68 citations , April 2002 in “Journal of Alternative and Complementary Medicine”

This study suggests that botanical 5AR inhibitors like Serenoa repens and β-sitosterol may improve symptoms of androgenetic alopecia, with 60% of treated subjects showing improvement compared to placebo.

research Causes and Management of Hypertrichosis

61 citations , January 2002 in “American Journal of Clinical Dermatology”

research Topical Eflornithine: Efficacy in Reducing Unwanted Facial Hair Growth in Women

115 citations , January 2001 in “American journal of clinical dermatology”

This study found that eflornithine 15% cream reduced unwanted facial hair growth more effectively than a placebo in women with hirsutism, but hair growth returned to pretreatment levels within 8 weeks of stopping treatment.

research A Prospective, Randomized Trial Comparing Flutamide (250 mg/d) and Finasteride (5 mg/d) in the Treatment of Hirsutism

50 citations , May 2000 in “Fertility and Sterility”

This study found that flutamide was more effective than finasteride in reducing hair growth in women with hirsutism over a one-year period.

research Management of Hirsutism

55 citations , March 2000 in “American journal of clinical dermatology”

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

research The SAHA Syndrome: Overview and Classification

70 citations , January 2000 in “Hormone Research in Paediatrics”

This article reviews the characteristics and classification of SAHA syndrome and its relationship with other conditions, without presenting new clinical findings.

research Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial

46 citations , January 2000 in “The Journal of Clinical Endocrinology and Metabolism”

research Comparison of Finasteride Versus Flutamide in the Treatment of Hirsutism

75 citations , October 1999 in “European journal of endocrinology”

This study found that both finasteride and flutamide effectively reduce hirsutism in women with polycystic ovary syndrome or idiopathic hirsutism, but flutamide was more effective.

A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism

research A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism

23 citations , April 1999 in “The Journal of Clinical Endocrinology and Metabolism”

This study found that flutamide, finasteride, ketoconazole, and EE-CPA all significantly reduced hirsutism scores, hair diameter, and hair growth rate in women with hirsutism over 12 months.

research Current Aspects of Antiandrogen Therapy in Women

20 citations , January 1999 in “Current Pharmaceutical Design”

This study reports that various antiandrogen therapies, including spironolactone and finasteride, effectively address hirsutism, acne, androgenic alopecia, and ovulatory dysfunction in hyperandrogenic women and are generally well tolerated.

research Incidence of Increased Androgen Levels in Patients Suffering from Acne

29 citations , January 1998 in “Dermatology”

This research reports that many acne patients have elevated androgen levels, contributing to a cycle that may lead to polycystic ovarian disease and potentially sterility.

research Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment

30 citations , January 1998 in “Dermatology”

This review discusses hormonal influences and treatment considerations in female acne, particularly highlighting the role of androgens in persistent or resistant cases, and reports no new clinical findings.

research Comparison of Finasteride Versus Spironolactone in the Treatment of Idiopathic Hirsutism

76 citations , December 1997 in “Fertility and Sterility”

This study found that spironolactone was significantly more effective than finasteride in reducing hirsutism scores over 9 months, despite more side effects occurring in the spironolactone group.

research Finasteride in the Treatment of Hirsutism: New Therapeutic Perspectives

50 citations , July 1996 in “Fertility and Sterility”

This study found that finasteride significantly reduced hirsutism scores in women with idiopathic hirsutism and PCOS, despite no changes in serum androgen levels.

research Polycystic Ovary Syndrome: Clinical and Biochemical Features

1947 citations , September 1995 in “New England journal of medicine/The New England journal of medicine”

This article discusses the heterogeneity of polycystic ovary syndrome, its association with insulin resistance, and its implications for long-term health, but reports no new clinical results.

research Clinical, Ultrasound, and Hormonal Markers of Androgenicity in Acne Vulgaris

57 citations , August 1995 in “British Journal of Dermatology”

In this study, acne severity in females was strongly associated with inflammatory lesion count and moderately associated with androgens, especially DELTA 4 and DHEAS promoting acne and SHBG reducing it.

A Prospective Study of the Prevalence of Clear-Cut Endocrine Disorders and Polycystic Ovaries in 350 Patients Presenting with Hirsutism or Androgenic Alopecia

research A Prospective Study of the Prevalence of Clear-Cut Endocrine Disorders and Polycystic Ovaries in 350 Patients Presenting with Hirsutism or Androgenic Alopecia

135 citations , August 1994 in “Clinical Endocrinology”

In this study of women with hirsutism or androgenic alopecia, diverse underlying endocrine disorders including polycystic ovaries and various enzyme deficiencies were detected, often associated with elevated testosterone levels.

research Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist and Estrogen Replacement Therapy

19 citations , March 1994 in “Fertility and sterility”

This study found that treatment with a GnRH agonist and estrogen and progestin replacement significantly improved hirsutism scores and hair growth rates in women with polycystic ovarian disease.

research Comparison of Flutamide and Spironolactone in the Treatment of Hirsutism: A Randomized Controlled Trial

165 citations , February 1994 in “Fertility and Sterility”

This study found that flutamide was more effective than spironolactone in reducing symptoms of hirsutism and related conditions in premenopausal women, with fewer discontinuations due to side effects.

research Cyproterone Acetate for Severe Hirsutism: Results of a Double-Blind Dose-Ranging Study

94 citations , July 1991 in “Clinical endocrinology”

In this study, cyproterone acetate at 2 mg daily was found to be as effective as higher doses in reducing hair growth for hirsute women over 12 months.

research Ketoconazole Therapy for Women with Acne and/or Hirsutism

46 citations , August 1990 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

In this study, ketoconazole treatment improved acne in all women and reduced hirsutism in some, but it caused several side effects and requires careful monitoring.

research Treatment of Hirsutism With Cimetidine: A Prospective Randomized Controlled Trial

17 citations , February 1989 in “Fertility and sterility”

In this study, cimetidine at a daily dose of 1.5 gm for 3 months did not significantly affect hair growth in women with moderate to severe hirsutism.

research Side Effects of Spironolactone Therapy in the Hirsute Woman

80 citations , January 1988 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

This study observed that high-dose spironolactone frequently caused metrorrhagia in women with idiopathic hirsutism, leading the authors to suggest lower starting doses or additional hormonal therapy.

research Treatment of Female Androgenetic Alopecia With Cimetidine

19 citations , March 1987 in “International Journal of Dermatology”

This study reports that cimetidine treatment resulted in good to excellent hair regrowth in 70% of the small group of women with androgenetic alopecia, with no major side effects observed.

research The Effect of Spironolactone on Hirsutism and Female Androgen Metabolism

32 citations , August 1985 in “Clinical endocrinology”

This study concluded that spironolactone may be an effective therapy for a subgroup of hirsute patients, as it reduced plasma testosterone and improved certain hair growth measures.

research Treatment of Hirsutism with Spironolactone

21 citations , March 1982 in “JAMA”

This study found that spironolactone at 200 mg/day effectively reduced facial hair growth in women with moderate to severe hirsutism, with improvements observed within two months and sustained over one year.